Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Board Meeting
|
Turnaround Potential
1333.7000
-8.40
(
-0.63
%)
NSE
Apr 02, 2026
15:31 PM
New 52W High in past week
Volume:
1.9M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
29 May 2023
Board Meeting
1333.70
-0.63%
Aurobindo Pharma Limited
Hold:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 615
Target
ICICI Direct
Geojit BNP Paribas increased Buy price target of Aurobindo Pharma Ltd. to 1502.0 on 01 Apr, 2026.
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020